This has been linked to lifestyle changes, metabolic diseases, and obesity, with cases increasingly being reported in women ...

Part of that spike is due to rising rates of cancers that affect primarily women, including breast cancer and endometrial ...

The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial ...

GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant ...

Merck and Eisai said on Friday a combination of their cancer therapies failed to extend the lives of patients with a type of ...

Uterine manipulation with an intrauterine device is the surgical method used for early-stage cervical cancer. In this study, ...

GSK’s Jemperli is designed to help the body’s immune system find and attack cancer cells, and is already approved in the EU ...

Meanwhile, J&J has claimed EU approval for its combination of EGFRxMET bispecific antibody Rybrevant (amivantamab) with third ...

GSK (GSK) announced the European Commission has approved Jemperli, or dostarlimab, in combination with chemotherapy for first-line treatment of ...

European Commission approves GSK’s Jemperli plus chemotherapy to treat patients with primary advanced or recurrent endometrial cancer: London, UK Tuesday, January 21, 2025, 09:0 ...

London: GSK plc has announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy ...